PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Is Partnership for Safe Medicines funded by pharmaceutical companies to smear PharmacyChecker?

Today, Tod Cooperman, MD, CEO and founder of PharmacyChecker and I sent the letter below to the Partnership for Safe Medicines (safemedicines.org) (PSM) asking them to correct information on their website that we believe is defamatory against PharmacyChecker. For years, the group was run by a vice president of Pharmaceutical Researchers and Manufacturers of America and continues what we believe is a smear campaign against PharmacyChecker – one funded by drug companies.

It’s not that they shouldn’t oppose drug importation as a means to lower drug prices: while I disagree with them, that’s fair game. What is not fair is publishing and making misleading, sometimes utterly false, statements that prompt people to avoid safe international online pharmacies that sell medicine they can actually afford. We’re tired of it.

Upon PSM correcting the information on their website, this blog post will be updated accordingly.

January 4, 2019

Mr. Shabbir J. Safdar
Executive Director
Partnership for Safe Medicines
315 Montgomery St, Suite 900
San Francisco, CA 94104

            Re:      Defamatory Misstatements about PharmacyChecker.com LLC published by

                        Partnership for Safe Medicines (SafeMedicines.org) (“PSM”)

Sent by email: shabbir@safemedicines.org

Dear Mr. Safdar:

We write to strongly urge that you correct, revise, or remove content that you recently published on your website (https://www.safemedicines.org/2018/11/drug-importation-is-a-bad-idea.html) that is rife with inaccurate, misleading, and defamatory assertions about our company, PharmacyChecker.com. This has been a modus operandi of your drug company-funded organization for many years, as exposed by independent reporting [See: https://khn.org/news/non-profit-linked-to-phrma-rolls-out-campaign-to-block-drug-imports/]. 

Attacking PharmacyChecker appears to us to be part of the Partnership for Safe Medicine’s smear campaign to frighten the U.S. public from purchasing prescription medication at lower prices from safe international online pharmacies. We understand that your campaign includes massive lobbying and public relations efforts against drug importation legislation, which, if enacted, would help lower drug prices. 

Among your offending statements are the following:

(more…)
Share
Tagged with:

Were you prescribed opioids instead of OTC pain meds?

According to a new study, it turns out that, potentially, millions of people should have been prescribed over-the-counter drugs—not addictive narcotics. That’s a major finding considering 600,0000 Americans have died from drug overdose between 1999-2016. The Journal of the American Medical Association (JAMA) study shows that over-the-counter medications, such as ibuprofen, acetaminophen, aspirin and naproxen may work better than the hard, addictive stuff, such as Vicodin, Oxycontin, and Fentanyl.

We recognize and respect the role that properly prescribed prescription narcotics have played and will continue to play in pain management. However, we also believe that Big Pharma makers and sellers of opioids caused this national crisis of drug addiction by helping to create looser prescribing rules. In other words, while at one-time opioid medications were viewed as a last resort to treat serious pain, drug companies pushed medical education that led to the prescribing of opioid drugs. The U.S. Centers for Disease Control and Prevention has revised its guidelines to encourage far tighter prescribing practices, but, as this study indicates, their revisions came way too late.

Patients Who Took Opioids

The JAMA study looked at 248 patients with varying levels of pain, back pain being the most prevalent form affecting 65% of patients. Others had pain associated with hip, knee and that associated with osteoarthritis. One group of patients were prescribed opioid medications. They started with fast acting morphine, a combination of hydrocodone and acetaminophen, or oxycodone. Long acting medications, morphine or oxycodone, were used when the short acting treatments were not working. When those did not work, fentanyl patches were prescribed.

Patients Who Took Non-opioids

Another group took NSAIDs. If NSAIDs did not work, then the group took other prescription medications, such as gabapentin (Neurontin) or pregabalin (Lyrica). If those didn’t work, then tramadol, which is an opioid-based painkiller but less addictive than the ones in the opioid group.

Results of the Study

Patients in the non-opioid group reported equal or better results in pain alleviation than patients in the opioid group. Admittedly, I’m confused because tramadol was in the non-opioid group, even though it’s an opiate-based medication. Also, one shortcoming variable of the study is that patients knew what medications they were taking, which could have biased their reporting.

Overall, the study strongly demonstrates that millions who were prescribed strong opioid drugs and became hooked could just as well have been treated initially with regular OTC pain medications. Not surprisingly, patients could have also saved billions of dollars over the last few decades by taking aspirin instead of brand-name prescription opioids.

This has really caught my attention because the industry-funded groups like the Alliance for Safe Online Pharmacies and Partnership for Safe Medicines equates importation from Canada with the opioid crisis. Instead of urging people to seek alternatives to opioids, the pharmaceutical industry propagates the senseless idea that increasing imports of lower cost (non-pain) medications from Canada will worsen the opioid crisis. They would rather point fingers than address the sickness of their complicity in creating the drug addiction crisis in the first place.

Share
Tagged with: , , , , , ,

Former U.S. FDA Commissioner Says 29 Countries Have Pharmaceutical Regulatory Systems Comparable to U.S.

Something unexpected happened at a dog and pony show staged at the National Press Club on April 4, where the Partnership for Safe Medicines (PSM) gave its campaign against prescription drug importation and international online pharmacies the imprimatur of technocratic expertise. Former FDA Commissioner Dr. Andrew Von Eschenbach, in opposing importation as unsafe, and “frightening” said that 29 countries have regulatory systems for drug safety comparable to the U.S. Was that a mistake? No. We need to get that list of 29 countries and create standards for distribution and refine guidance for consumers to help more Americans import lower cost medications from those countries.

I derived the number 29 because Dr. Eschenbach said: “of the 96 countries around the world that can supply drugs only 30% have a functional regulatory infrastructure that’s comparable to the one that we have at the Food and Drug Administration.” Simple math showed 30% of 96 is 28.8. I rounded to 29!

Granted, Dr. Eschenbach would say that I was taking his words out of context. (more…)

Share
Tagged with: , , ,